{"id":"ca7fda2b-9985-4292-9c82-308870660dcb","kind":"companies","code":"UB-C3572","name":"Yuanqizhihui","nameBasis":"transliterated","summary":"Yuanqizhihui is a company headquartered in Beijing, China.","description":"","country":"China","category":null,"originalName":"缘启智慧","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:10:30.060Z","englishUpdatedAt":"2026-10-20T18:26:36.308Z","reviewedAt":"2026-10-20T18:26:36.308Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"70aeb588bf30750fa50e9e95c8557794a458ef61e1de02bdf3bea8c892bdb5a3","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"f314b0cb-6fd8-4e94-a75f-39bf1ce10c15","kind":"people","code":"UB-P2545","name":"Deng Jiang","nameBasis":"transliterated","summary":"Deng Jiang holds a master’s degree in systems engineering from Tianjin University and is a senior engineer. Founder and CEO of Yuanqi Wisdom, a medical AI large-model company, and deputy chair of the Beijing professional committee for intelligent pharmacy. Leads research and application of multimodal evidence-based medical AI models, promoting practical integration of AI in healthcare. The company’s medical AI agent MentX ranked first in China in an authoritative international medical multimodal reasoning benchmark, according to the source.","description":"Deng Jiang holds a master’s degree in systems engineering from Tianjin University and is a senior engineer. Founder and CEO of Yuanqi Wisdom, a medical AI large-model company, and deputy chair of the Beijing professional committee for intelligent pharmacy. Leads research and application of multimodal evidence-based medical AI models, promoting practical integration of AI in healthcare. The company’s medical AI agent MentX ranked first in China in an authoritative international medical multimodal reasoning benchmark, according to the source.","country":null,"category":null,"originalName":"邓江","eventDate":null,"website":"https://uniquebloom.cn/member/48896c7c-0fc0-4a89-99e7-cd1ddd231153","sourceUpdatedAt":"2026-10-17T15:20:14.537Z","englishUpdatedAt":"2026-10-20T18:28:47.179Z","reviewedAt":"2026-10-20T18:28:47.179Z","snapshotAt":"2026-10-20T18:07:42.467Z","sourceHash":"04e1e5e2b547bfd790d5075aa2b77a80fe2f4801a2b8be9c951b824fbc51670f","companyId":"ca7fda2b-9985-4292-9c82-308870660dcb","foundedYear":null,"logoUrl":null,"path":"/people/deng-jiang"},{"id":"1cb6d86c-551f-4784-972c-4b34705a7a9d","kind":"products","code":"UB-D1842","name":"Yiqizhen","nameBasis":"transliterated","summary":"Our core product, the AI General Practice Clinical Advisor, aims to serve as a professional advisor to doctors through technology with a human touch. It supports health consultations, clinical assistance, report interpretation, chronic disease management, and other scenarios. Human-machine collaboration enables more efficient and accurate medical decisions, allowing doctors to return to clinical judgment and spend more time with patients.","description":"Our core product, the AI General Practice Clinical Advisor, aims to serve as a professional advisor to doctors through technology with a human touch. It supports health consultations, clinical assistance, report interpretation, chronic disease management, and other scenarios. Human-machine collaboration enables more efficient and accurate medical decisions, allowing doctors to return to clinical judgment and spend more time with patients.","country":null,"category":"Medical assistants","originalName":"医启诊","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T17:16:12.534Z","englishUpdatedAt":"2026-10-20T18:28:54.551Z","reviewedAt":"2026-10-20T18:28:54.551Z","snapshotAt":"2026-10-20T18:06:34.551Z","sourceHash":"0455ffd59b342ed90918bf742d92a38bac3471ce01a0a94737d4dc6bb72f49d6","companyId":"ca7fda2b-9985-4292-9c82-308870660dcb","foundedYear":null,"logoUrl":"https://c.ux-cdn.com/1863156737900573-5aba7b40bf5e48ca8be5896e57b70eca/uniquebase%2Flogos%2Fproduct%2Freczz28IxQdnndJr%2Fa907db545ef1485f7a2e4e7adee653b0f79c12e9d59e5b870c703325c7a9f7b2.png","path":"/products/yiqizhen"},{"id":"a7881fcb-43ff-4e3e-a312-275f1ed27f26","kind":"news","code":"a7881fcb-43ff-4e3e-a312-275f1ed27f26","name":"Yuanqizhihui completes equity financing","nameBasis":"translated-title","summary":"On 2026-08-02, according to Xiniu Data, Yuanqizhihui completed equity financing for an undisclosed amount. Investors were Beijing Shenzhouxibao Biotechnology Technology Group Joint-stock Company. The company is a provider of medical AI technology research and development services.","description":"","country":null,"category":null,"originalName":"缘启智慧完成股权投资融资","eventDate":"2026-08-02T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T16:32:29.310Z","englishUpdatedAt":"2026-10-20T18:31:05.484Z","reviewedAt":"2026-10-20T18:31:05.484Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"88ebabaaf4d6ffb02519fea978506ca151f791b7fbbbaf1b2ad103cf0ac48d7f","companyId":"ca7fda2b-9985-4292-9c82-308870660dcb","foundedYear":null,"logoUrl":null,"path":"/news/a7881fcb-43ff-4e3e-a312-275f1ed27f26"},{"id":"38c40342-5dcc-400f-bae2-c58f73550f03","kind":"institutions","code":"UB-I7141","name":"北京神州细胞生物技术集团股份公司","nameBasis":"transliterated","summary":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","description":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","country":null,"category":null,"originalName":"北京神州细胞生物技术集团股份公司","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:00:21.106Z","englishUpdatedAt":"2026-10-15T18:45:27.684Z","reviewedAt":"2026-10-15T18:45:27.684Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"67722079f2dcbe58762be19f4b8ca1e9276aceb326c3739b60975f0f1ba25f43","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Beijing Shenzhouxibao Biotechnology Technology Group Joint-stock Company","path":"/institutions/beijing-shenzhouxibao-biotechnology-technology-group-joint-stock-company"}],"finance":{"funding":{"metric":"funding","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"a7881fcb-43ff-4e3e-a312-275f1ed27f26","date":"2026-08-02T00:00:00.000Z","round":"Equity","amountText":"金额未知","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":null,"institutions":[{"id":"38c40342-5dcc-400f-bae2-c58f73550f03","kind":"institutions","code":"UB-I7141","name":"北京神州细胞生物技术集团股份公司","nameBasis":"transliterated","summary":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","description":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","country":null,"category":null,"originalName":"北京神州细胞生物技术集团股份公司","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:00:21.106Z","englishUpdatedAt":"2026-10-15T18:45:27.684Z","reviewedAt":"2026-10-15T18:45:27.684Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"67722079f2dcbe58762be19f4b8ca1e9276aceb326c3739b60975f0f1ba25f43","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Beijing Shenzhouxibao Biotechnology Technology Group Joint-stock Company","path":"/institutions/beijing-shenzhouxibao-biotechnology-technology-group-joint-stock-company"}],"newsUrl":null,"evidence":{"headline":"Yuanqizhihui completes equity financing","brief":"On 2026-08-02, according to Xiniu Data, Yuanqizhihui completed equity financing for an undisclosed amount. Investors were Beijing Shenzhouxibao Biotechnology Technology Group Joint-stock Company. The company is a provider of medical AI technology research and development services.","basis":"translated-source-brief","newsPath":"/news/a7881fcb-43ff-4e3e-a312-275f1ed27f26","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"a7881fcb-43ff-4e3e-a312-275f1ed27f26","date":"2026-08-02T00:00:00.000Z","round":"Equity","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":null,"institutions":[{"id":"38c40342-5dcc-400f-bae2-c58f73550f03","kind":"institutions","code":"UB-I7141","name":"北京神州细胞生物技术集团股份公司","nameBasis":"transliterated","summary":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","description":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","country":null,"category":null,"originalName":"北京神州细胞生物技术集团股份公司","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:00:21.106Z","englishUpdatedAt":"2026-10-15T18:45:27.684Z","reviewedAt":"2026-10-15T18:45:27.684Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"67722079f2dcbe58762be19f4b8ca1e9276aceb326c3739b60975f0f1ba25f43","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Beijing Shenzhouxibao Biotechnology Technology Group Joint-stock Company","path":"/institutions/beijing-shenzhouxibao-biotechnology-technology-group-joint-stock-company"}],"newsUrl":null,"evidence":{"headline":"Yuanqizhihui completes equity financing","brief":"On 2026-08-02, according to Xiniu Data, Yuanqizhihui completed equity financing for an undisclosed amount. Investors were Beijing Shenzhouxibao Biotechnology Technology Group Joint-stock Company. The company is a provider of medical AI technology research and development services.","basis":"translated-source-brief","newsPath":"/news/a7881fcb-43ff-4e3e-a312-275f1ed27f26","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"a7881fcb-43ff-4e3e-a312-275f1ed27f26","kind":"funding","eventDate":"2026-08-02T00:00:00.000Z","revenueDate":null,"round":"股权投资","amountText":"金额未知","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":null,"newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"38c40342-5dcc-400f-bae2-c58f73550f03","kind":"institutions","code":"UB-I7141","name":"北京神州细胞生物技术集团股份公司","nameBasis":"transliterated","summary":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","description":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","country":null,"category":null,"originalName":"北京神州细胞生物技术集团股份公司","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:00:21.106Z","englishUpdatedAt":"2026-10-15T18:45:27.684Z","reviewedAt":"2026-10-15T18:45:27.684Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"67722079f2dcbe58762be19f4b8ca1e9276aceb326c3739b60975f0f1ba25f43","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Beijing Shenzhouxibao Biotechnology Technology Group Joint-stock Company","path":"/institutions/beijing-shenzhouxibao-biotechnology-technology-group-joint-stock-company"}],"roundName":"Equity","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[{"id":"f314b0cb-6fd8-4e94-a75f-39bf1ce10c15","kind":"people","code":"UB-P2545","name":"Deng Jiang","nameBasis":"transliterated","summary":"Deng Jiang holds a master’s degree in systems engineering from Tianjin University and is a senior engineer. Founder and CEO of Yuanqi Wisdom, a medical AI large-model company, and deputy chair of the Beijing professional committee for intelligent pharmacy. Leads research and application of multimodal evidence-based medical AI models, promoting practical integration of AI in healthcare. The company’s medical AI agent MentX ranked first in China in an authoritative international medical multimodal reasoning benchmark, according to the source.","description":"Deng Jiang holds a master’s degree in systems engineering from Tianjin University and is a senior engineer. Founder and CEO of Yuanqi Wisdom, a medical AI large-model company, and deputy chair of the Beijing professional committee for intelligent pharmacy. Leads research and application of multimodal evidence-based medical AI models, promoting practical integration of AI in healthcare. The company’s medical AI agent MentX ranked first in China in an authoritative international medical multimodal reasoning benchmark, according to the source.","country":null,"category":null,"originalName":"邓江","eventDate":null,"website":"https://uniquebloom.cn/member/48896c7c-0fc0-4a89-99e7-cd1ddd231153","sourceUpdatedAt":"2026-10-17T15:20:14.537Z","englishUpdatedAt":"2026-10-20T18:28:47.179Z","reviewedAt":"2026-10-20T18:28:47.179Z","snapshotAt":"2026-10-20T18:07:42.467Z","sourceHash":"04e1e5e2b547bfd790d5075aa2b77a80fe2f4801a2b8be9c951b824fbc51670f","companyId":"ca7fda2b-9985-4292-9c82-308870660dcb","foundedYear":null,"logoUrl":null,"path":"/people/deng-jiang"}],"productsRelated":[{"id":"1cb6d86c-551f-4784-972c-4b34705a7a9d","kind":"products","code":"UB-D1842","name":"Yiqizhen","nameBasis":"transliterated","summary":"Our core product, the AI General Practice Clinical Advisor, aims to serve as a professional advisor to doctors through technology with a human touch. It supports health consultations, clinical assistance, report interpretation, chronic disease management, and other scenarios. Human-machine collaboration enables more efficient and accurate medical decisions, allowing doctors to return to clinical judgment and spend more time with patients.","description":"Our core product, the AI General Practice Clinical Advisor, aims to serve as a professional advisor to doctors through technology with a human touch. It supports health consultations, clinical assistance, report interpretation, chronic disease management, and other scenarios. Human-machine collaboration enables more efficient and accurate medical decisions, allowing doctors to return to clinical judgment and spend more time with patients.","country":null,"category":"Medical assistants","originalName":"医启诊","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-18T17:16:12.534Z","englishUpdatedAt":"2026-10-20T18:28:54.551Z","reviewedAt":"2026-10-20T18:28:54.551Z","snapshotAt":"2026-10-20T18:06:34.551Z","sourceHash":"0455ffd59b342ed90918bf742d92a38bac3471ce01a0a94737d4dc6bb72f49d6","companyId":"ca7fda2b-9985-4292-9c82-308870660dcb","foundedYear":null,"logoUrl":"https://c.ux-cdn.com/1863156737900573-5aba7b40bf5e48ca8be5896e57b70eca/uniquebase%2Flogos%2Fproduct%2Freczz28IxQdnndJr%2Fa907db545ef1485f7a2e4e7adee653b0f79c12e9d59e5b870c703325c7a9f7b2.png","path":"/products/yiqizhen"}],"investors":[{"id":"38c40342-5dcc-400f-bae2-c58f73550f03","kind":"institutions","code":"UB-I7141","name":"北京神州细胞生物技术集团股份公司","nameBasis":"transliterated","summary":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","description":"Shenzhou Cell, a listed innovative biologic drug company undertaking strategic investments.","country":null,"category":null,"originalName":"北京神州细胞生物技术集团股份公司","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:00:21.106Z","englishUpdatedAt":"2026-10-15T18:45:27.684Z","reviewedAt":"2026-10-15T18:45:27.684Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"67722079f2dcbe58762be19f4b8ca1e9276aceb326c3739b60975f0f1ba25f43","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Beijing Shenzhouxibao Biotechnology Technology Group Joint-stock Company","path":"/institutions/beijing-shenzhouxibao-biotechnology-technology-group-joint-stock-company"}],"path":"/companies/yuanqizhihui-beijing-kejiyouxiangongsi","structured":{"city":"Beijing","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"Yuanqizhihui is a company headquartered in Beijing, China.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/companies/yuanqizhihui-beijing-kejiyouxiangongsi"}